The US Food and Drug Administration (FDA) admonished Japanese pharmaceutical manufacturer Toyoba Co. in a recent warning letter for taking a lax approach to fixing microbiological contamination issues ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results